Brief: Transcenta Announces Collaboration And Non-Exclusive Licensing Agreement With Eirgenix Inc.
29/12/2025 01:17
Dec 29 (Reuters) - Transcenta Holding Ltd 6628.HK: ANNOUNCES COLLABORATION AND NON-EXCLUSIVE LICENSING AGREEMENT WITH EIRGENIX INC. GRANTS EIRGENIX NON-EXCLUSIVE LICENSE FOR ITS HIGHLY INTENSIFIED CONTINUOUS BIOPROCESSING PLATFORM Further company coverage: 6589.TW ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcenta Holding
See all newsBrief: Transcenta Says Global Phase III Trial Of Osemitamab Approved By FDA, China, Korea Regulators
Brief: Transcenta Holding Says Unit To Sell CDMO Assets For RMB190.0 Million
Brief: Transcenta Holding To Revert Assets To Lilly For $4 Million Cash
Brief: Transcenta Therapeutics Appoints Dr. Christopher Hwang As Head Of Global Partnerships For Hicb Platform
Brief: Transcenta Announces Collaboration And Non-Exclusive Licensing Agreement With Eirgenix Inc.